EMA Centralised Procedure Strategy for First-Time Applicants
                     First-Time EMA 
Centralised 
Procedure 
Applicant? Build the 
Right Regulatory 
Strategy from Day 
One
Eligibility | Scientific Advice | 
Dossier Readiness | Risk 
Mitigation | Successful 
Submission
Your Challenge Our Value
Regulatory uncertainty Strategic clarity
Limited EMA experience Expert navigation
Cross-functional misalignment Integrated planning
Submission risks Early risk mitigation
Complex agency interactions Effective EMA engagement
Unclear timelines Realistic roadmaps
Readiness gaps Enhanced submission 
preparedness
For first-time applicants, the EMA Centralised Procedure can seem complex, 
with multiple stakeholders, strict timelines, and high expectations. A well-
defined regulatory strategy early in development can significantly improve 
the chances of a smooth and successful marketing authorisation journey.
Launching a product through the EMA Centralised Procedure (CP) for the 
first time is more than just submitting a dossier. It requires a comprehensive 
regulatory strategy that aligns scientific development, compliance 
requirements, and commercial objectives from the outset.
Key areas where strategic regulatory 
guidance adds value
Eligibility Assessment Dossier Readiness & Gap 
Confirm whether your product Analysis
qualifies for the Centralised Identify potential deficiencies 
Procedure and identify the most early, strengthen supporting data 
appropriate submission pathway. packages, and ensure CTD 
submissions are inspection and 
Regulatory Roadmap Development review ready.
Establish clear milestones, Stakeholder & Question 
submission timelines, and Management
critical regulatory interactions Navigate rapporteur interactions, 
to minimize delays and optimize List of Questions (LoQ), and List of 
resources. Outstanding Issues (LoOI) 
effectively through strategic 
Scientific & Regulatory Advice planning and timely responses.
Preparation Risk Mitigation
Maximize the value of Scientific Anticipate regulatory risks, 
Advice meetings by proactively procedural bottlenecks, and 
addressing development challenges compliance concerns before they 
and aligning with EMA expectations. impact approval timelines.
A strong submission starts long before 
dossier compilation. Strategic 
regulatory planning is the foundation 
of regulatory success.
For emerging biopharmaceutical companies and organizations 
entering the European market for the first time, expert regulatory 
planning can transform a complex process into a structured 
pathway toward successful authorization.
Reach out to our Experts to know more at
[email protected]